Surgery Partners Inc. (SGRY)
24.00
-0.12 (-0.50%)
At close: Mar 28, 2025, 1:39 PM
Surgery Partners Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 3.11B | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.6M | 260.21M |
Cost of Revenue | 2.37B | 2.1B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.2M | 669.33M | 254.18M | 169.84M | 159.35M |
Gross Profit | 745.6M | 647.5M | 574.9M | 491.4M | 379.8M | 423.8M | 410.02M | 327.42M | 324.24M | 290.56M | 149.11M | 114.75M | 100.87M |
Operating Income | 348.8M | 328M | 345.2M | 302.2M | 246.6M | 235.9M | 77.84M | 158.23M | 196.48M | 144.75M | 50.81M | 58.23M | 60.45M |
Interest Income | n/a | n/a | 227M | 220.9M | 201.8M | 178.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 147.1M | 135M | 110.3M | 81.2M | -18.8M | 54.6M | -69.17M | 82.29M | 92.18M | -76.14M | -11.29M | 25.3M | 31.97M |
Net Income | -168.1M | -11.9M | 87M | 70.7M | 1.3M | 46.1M | -205.71M | -52.98M | 9.45M | 1.43M | -65.9M | -9.06M | 1.92M |
Selling & General & Admin | 495.8M | 120.9M | 102.2M | 104M | 97.1M | 88.6M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 198.6M | 112.4M | 60.9M | 48.6M | 75.1M | 63.67M | 25.33M | -3.73M | -119.91M | 21.21M | 17.84M | 14.32M |
Operating Expenses | 495.8M | 319.5M | 214.6M | 164.9M | 145.7M | 163.7M | 157.23M | 156.37M | 123.66M | 111.83M | 52.66M | 44.18M | 39.58M |
Interest Expense | 201.7M | 193M | 234.9M | 221M | 201.8M | 178.9M | 147M | 117.67M | 100.57M | 100.98M | 62.1M | 32.93M | 28.48M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.86B | 2.42B | 2.18B | 1.9B | 1.63B | 1.57B | 1.52B | 1.17B | 944.85M | 781.15M | 306.84M | 214.03M | 198.93M |
Income Tax | 134.6M | 300K | 23.3M | 10.5M | -20.1M | 8.5M | 26.46M | 53.55M | 7.09M | -148.98M | 15.76M | 7.57M | 6.11M |
Shares Outstanding (Basic) | 126.12M | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.69M | 48.02M | 36.07M | 48.16M | 48.16M | 48.16M |
Shares Outstanding (Diluted) | 126.12M | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 49M | 48.19M | 37.46M | 48.16M | 48.16M | 48.16M |
EPS (Basic) | -1.33 | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
EPS (Diluted) | -1.33 | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.08 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
EBITDA | 501.4M | 446.1M | 460M | 401M | 277.8M | 336.6M | 144.68M | 251.88M | 245.23M | 59.39M | 65.87M | 69.89M | 72.49M |
Depreciation & Amortization | 152.6M | 118.1M | 149.6M | 137.9M | 134.2M | 116.5M | 67.44M | 51.93M | 39.55M | 34.55M | 15.06M | 11.66M | 11.21M |